Safety and efficacy of conversion from once daily Sandimmun to twice daily Neoral cyclosporine in renal allograft recipients.
W. T. Lee
Y. M. Lu
K. T. Woo
View on PubMed
Abstract & Figures
Sorry, we couldn't extract an abstract for this paper.
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Slides referencing similar topics
Off-Label Use of Cyclosporine in Eye Care
William D. Townsend • Oct 18, 2017
WITH tacrolimus can worsen/induce kidney dysfunction: gentamicin, tobramycin, amphotericin B, cisplatin and cyclosporine
Sirolimus Rapamune • Aug 27, 2017
FDA approved therapeutics Gadolinium chelate for MRI imaging (Gd- DTPA Dimeglumine) Iron oxide particles for MRI imaging (Feridex) Products using NanoCrystal technology (Rapamune, Emend) Liposomes (Doxil, DaunoXome) Microemulsions (Cyclosporine) Albumin-bound nanoparticles (Abraxane)
Patti Glaza • Oct 18, 2017